These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25449862)

  • 1. Connexins, gap junctions and peripheral neuropathy.
    Kleopa KA; Sargiannidou I
    Neurosci Lett; 2015 Jun; 596():27-32. PubMed ID: 25449862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of X-linked Charcot-Marie-Tooth disease.
    Kleopa KA; Scherer SS
    Neuromolecular Med; 2006; 8(1-2):107-22. PubMed ID: 16775370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gap junction disorders of myelinating cells.
    Kleopa KA; Orthmann-Murphy J; Sargiannidou I
    Rev Neurosci; 2010; 21(5):397-419. PubMed ID: 21280457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
    Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
    Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
    Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
    Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
    Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
    Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked Charcot-Marie-Tooth disease.
    Scherer SS; Kleopa KA
    J Peripher Nerv Syst; 2012 Dec; 17 Suppl 3(0 3):9-13. PubMed ID: 23279425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin32 and X-linked Charcot-Marie-Tooth disease.
    Bone LJ; Deschênes SM; Balice-Gordon RJ; Fischbeck KH; Scherer SS
    Neurobiol Dis; 1997; 4(3-4):221-30. PubMed ID: 9361298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X.
    Kleopa KA; Zamba-Papanicolaou E; Alevra X; Nicolaou P; Georgiou DM; Hadjisavvas A; Kyriakides T; Christodoulou K
    Neurology; 2006 Feb; 66(3):396-402. PubMed ID: 16476939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease.
    Olympiou M; Sargiannidou I; Markoullis K; Karaiskos C; Kagiava A; Kyriakoudi S; Abrams CK; Kleopa KA
    Acta Neuropathol Commun; 2016 Sep; 4(1):95. PubMed ID: 27585976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?
    Kleopa KA; Abrams CK; Scherer SS
    Brain Res; 2012 Dec; 1487():198-205. PubMed ID: 22771394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GJB1-associated X-linked Charcot-Marie-Tooth disease, a disorder affecting the central and peripheral nervous systems.
    Abrams CK; Freidin M
    Cell Tissue Res; 2015 Jun; 360(3):659-73. PubMed ID: 25370202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.
    Abrams CK; Freidin M; Bukauskas F; Dobrenis K; Bargiello TA; Verselis VK; Bennett MV; Chen L; Sahenk Z
    J Neurosci; 2003 Nov; 23(33):10548-58. PubMed ID: 14627639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
    Kyriakoudi S; Sargiannidou I; Kagiava A; Olympiou M; Kleopa KA
    Hum Mol Genet; 2017 May; 26(9):1622-1633. PubMed ID: 28334782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
    Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
    J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.
    Freidin M; Asche-Godin S; Abrams CK
    Exp Neurol; 2015 Jan; 263():339-49. PubMed ID: 25447941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two novel mutations of GJB1 gene associated with typical X-linked Charcot-Marie-Tooth disease].
    Qiao XH; Li YX; Chang XZ; Luan XH; Chen B; Bu DF; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3328-31. PubMed ID: 20193560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.
    Vavlitou N; Sargiannidou I; Markoullis K; Kyriacou K; Scherer SS; Kleopa KA
    J Neuropathol Exp Neurol; 2010 Sep; 69(9):945-58. PubMed ID: 20720503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease.
    Ressot C; Bruzzone R
    Brain Res Brain Res Rev; 2000 Apr; 32(1):192-202. PubMed ID: 10751670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
    Abrams CK; Bennett MV; Verselis VK; Bargiello TA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.